1-198703360-A-G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002838.5(PTPRC):c.646A>G(p.Thr216Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,612,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T216P) has been classified as Likely benign.
Frequency
Consequence
NM_002838.5 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 104Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- T-B+ severe combined immunodeficiency due to CD45 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002838.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PTPRC | NM_002838.5 | MANE Select | c.646A>G | p.Thr216Ala | missense | Exon 7 of 33 | NP_002829.3 | ||
| PTPRC | NM_080921.4 | c.163A>G | p.Thr55Ala | missense | Exon 4 of 30 | NP_563578.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PTPRC | ENST00000442510.8 | TSL:1 MANE Select | c.646A>G | p.Thr216Ala | missense | Exon 7 of 33 | ENSP00000411355.3 | ||
| PTPRC | ENST00000348564.12 | TSL:1 | c.163A>G | p.Thr55Ala | missense | Exon 4 of 30 | ENSP00000306782.7 | ||
| PTPRC | ENST00000530727.5 | TSL:1 | c.304A>G | p.Thr102Ala | missense | Exon 5 of 18 | ENSP00000433536.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152116Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 250538 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460708Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726722 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74312 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.640A>G (p.T214A) alteration is located in exon 7 (coding exon 6) of the PTPRC gene. This alteration results from a A to G substitution at nucleotide position 640, causing the threonine (T) at amino acid position 214 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at